How do Jardiance and Januvia compare side by side?
From the US Jardiance and Januvia labels; trial rows from Roden 2013. The four rows above are the short version.
Show all 9 rowsHide table
| Jardiance (empagliflozin) | Januvia (sitagliptin) | |
|---|---|---|
| Drug class | SGLT2 inhibitor1 | DPP-4 inhibitor2 |
| Approved for | Heart failure; chronic kidney disease; lowering cardiovascular death in type 2 diabetes with heart disease; blood sugar in type 2 diabetes from age 101 | Blood sugar control in adults with type 2 diabetes2 |
| Label dosing | 10 mg once a day in the morning; for blood sugar may go to 25 mg1 | 100 mg once a day; 50 mg or 25 mg with lower kidney function2 |
| Kidney limit | Not for blood sugar control when eGFR is under 301 | Dose lowered when eGFR is under 452 |
| Half-life | About 12.4 hours1 | About 12.4 hours2 |
| Time to peak | 1.5 hours1 | 1 to 4 hours2 |
| Most common side effects (5% or more) | Urinary tract infections and female genital yeast infections1 | Upper respiratory infection, stuffy or runny nose and sore throat, headache2 |
| Before surgery | Hold at least 3 days, if possible, because of ketoacidosis risk1 | No such instruction in the dosing section2 |
| HbA1c vs placebo, 24 weeks (Roden 2013) | −0.74% (10 mg) and −0.85% (25 mg)3 | −0.73% (100 mg)3 |
Reviewed . Half-life figures are shown only where the value Dose Track uses agrees with the cited source.
How does each lower blood sugar?
Jardiance blocks SGLT2 in the kidneys, so more sugar leaves in the urine. That is also why its common side effects are urinary and genital infections.1 Januvia blocks DPP-4, the enzyme that breaks down the gut hormones GLP-1 and GIP, which help the body release insulin after meals.2
Have they been tested in the same trial?
Yes, but against placebo. Roden and colleagues randomized 899 adults with type 2 diabetes who had not taken diabetes medicine in the previous 12 weeks to placebo, empagliflozin 10 mg, empagliflozin 25 mg or sitagliptin 100 mg for 24 weeks. Compared with placebo, HbA1c fell 0.74%, 0.85% and 0.73% more.3 The abstract reports each drug against placebo, not a direct test of one drug against the other.
Side effects of any kind were reported by 55% (10 mg), 60% (25 mg) and 53% (sitagliptin), vs 61% on placebo.3 The trial was paid for by the makers of empagliflozin.3
Why is only Jardiance approved beyond blood sugar?
Jardiance has outcome trials in heart and kidney disease, including EMPA-REG OUTCOME in 7,020 adults with type 2 diabetes and heart disease, and the label lists those uses.1 The Januvia label is for blood sugar only, and warns that heart failure was seen in outcome trials of two other drugs in its class.2
More detail: Jardiance side effects, the Jardiance dosing schedule, and the Empagliflozin and Sitagliptin guides.
Frequently asked questions
Can Jardiance and Januvia be taken together?
They work in different ways, but whether to combine them is a decision for your prescriber; this page does not cover using them together.
Which lowers HbA1c more?
In the one trial that tested both, each was compared with placebo: HbA1c fell 0.74% and 0.85% more on empagliflozin 10 and 25 mg, and 0.73% more on sitagliptin, over 24 weeks. The abstract does not report a direct test between them.3
Why should Jardiance be stopped before surgery?
Because of ketoacidosis risk, which can happen with near-normal blood sugar. The label says to hold it at least 3 days before surgery or long fasting, if possible.1
Can I track both in Dose Track?
Yes. Log each daily tablet with reminders, and keep your data on your phone.
Related comparisons
- Januvia vs Ozempic: how do sitagliptin and semaglutide compare?Daily DPP-4 tablet vs weekly GLP-1 shot
- Jardiance vs Farxiga: how do the two SGLT2 tablets compare?Empagliflozin vs dapagliflozin, from the labels
- Metformin vs Jardiance: how do the two diabetes tablets differ?Biguanide vs SGLT2 tablet, plus the combination trial
- Ozempic vs Jardiance: how do they differ for type 2 diabetes?Weekly GLP-1 pen vs daily SGLT2 tablet
- Free reconstitution calculatorVial strength and water to syringe units
See also
- Januvia side effects
- Januvia dosing schedule
- I missed my Januvia dose. What should I do?
- Janumet vs Synjardy: how do the two metformin combinations differ?
- Steglujan vs Glyxambi: how do the two SGLT2 and DPP-4 tablets differ?
Track it in Dose Track: GLP-1 tracker, TRT tracker or peptide tracker.
Sources
- Jardiance (empagliflozin) tablets prescribing information, sections 1, 2, 3, 6.1, 8.6, 12.3 and 14. DailyMed, version of January 2026.
- Januvia (sitagliptin) tablets prescribing information, sections 1, 2, 3, 5, 6.1, 12.3 and 14. DailyMed, version 71.
- Roden M, et al. Empagliflozin monotherapy with sitagliptin as an active comparator in patients with type 2 diabetes: a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Diabetes Endocrinol. 2013;1:208-219.
All compound comparisons · Empagliflozin guide · Sitagliptin guide · All compound guides · Peptide tracking in Dose Track